Enanta Pharmaceuticals | Lngresos Netos

Net Income Cambio Fecha
AbbVie USD 822M 956M 2023-12
Amgen USD 767M 963M 2023-12
Arrowhead Research USD -132864000 23.18M 2023-12
AstraZeneca USD 1.37B 444M 2023-09
BioCryst Pharmaceuticals USD -36149000 39.18M 2023-09
Biogen USD 249.7M 317.8M 2023-12
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Enanta Pharmaceuticals USD -28107000 10.96M 2023-09
Gilead Sciences USD 1.43B 751M 2023-12
GlaxoSmithKline GBP 1.46B 160M 2023-09
Halozyme Therapeutics USD 85.39M 3.55M 2023-12
Heron Therapeutics USD -25008000 17.05M 2023-09
Incyte USD 201.08M 29.81M 2023-12
Insmed USD -186061000 27.13M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Ligand Pharmaceuticals USD 18.19M 28.46M 2023-12
Marinus Pharmaceuticals USD -32972000 1.04M 2023-09
Merck USD -1226000000 5.97B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Novartis USD 1.76B 553M 2023-09
Novavax USD -130776000 188.78M 2023-09
Pfizer USD -3368000000 986M 2023-12
PTC Therapeutics USD -155792000 22.82M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD -40937000 17M 2023-09
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



Enanta Pharmaceuticals Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.